Evidence map›Paper›PMID 29177662›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2018

Detecting Posttranslational Modifications of Hsp90.

Rebecca A Sager, Mark R Woodford, Len Neckers, Mehdi Mollapour

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Inhibitors of HSP90 in melanoma.Apoptosis : an international journal on programmed cell death · 2020
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rebecca A SagerDepartment of Urology, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA.
Mark R WoodfordDepartment of Urology, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA.
Len NeckersUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
Mehdi MollapourDepartment of Urology, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA. mollapom@upstate.edu.
SUNY Upstate Medical University · USNational Institutes of Health · US

Funding

Post-translational modifications of Hsp90 that impact drug efficacyZIABC011032 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NECKERS, LEONARD · 2009 to 2025
$11.5M
Regulatory mechanisms of the Hsp90 chaperone machinery.R35GM139584 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI MOLLAPOUR, MEHDI · 2021 to 2025
$2.2M
Crosstalk between post-translational regulations of the FNIP co-chaperones and their impact on Hsp90 chaperone function and drug bindingR01GM124256 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI MOLLAPOUR, MEHDI · 2017 to 2020
$1.3M
NIGMS NIH HHS R01 GM124256NIGMS NIH HHS R35 GM139584
6 · The paper itself

Abstract

The molecular chaperone Heat Shock Protein 90 (Hsp90) is essential in eukaryotes. Hsp90 chaperones proteins that are important determinants of multistep carcinogenesis. The chaperone function of Hsp90 is linked to its ability to bind and hydrolyze ATP. Co-chaperones as well as posttranslational modifications (phosphorylation, SUMOylation, and ubiquitination) are important for its stability and regulation of the ATPase activity. Both mammalian and yeast cells can be used to express and purify Hsp90 and also detect its posttranslational modifications by immunoblotting.

Indexed as

Protein Processing, Post-TranslationalAcetylationAnimalsBlotting, WesternHSP90 Heat-Shock ProteinsHumansPhosphorylationSaccharomyces cerevisiaeUbiquitinationHSP90 Heat-Shock ProteinsHeat shock protein 90 (Hsp90)Molecular chaperonesPhosphorylationPosttranslational modificationSUMOylationUbiquitination

Identifiers

PMID29177662
PMCPMC6376113
OpenAlexW2769161800

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.